Product References
AR-A014418 regulates intronic polyadenylation and transcription of PD-L1 through inhibiting CDK12 and CDK13 in tumor cells.
Journal for immunotherapy of cancer
Zhang G,Lan B,Zhang X,Lin M,Liu Y,Chen J,Guo F
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Mon May 01 00:00:00 EDT 2023
Sustained release of therapeutic gene by injectable hydrogel for hepatocellular carcinoma.
International journal of pharmaceutics: X
Xu S,Cai J,Cheng H,Wang W
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Fri Dec 15 00:00:00 EST 2023
Contribution of Mesenchymal Stem Cells from Obese Adipose Tissue to PD-L1 Over-Expression and Breast Cancer Progression through Pathogenic Th17 Cell Activation.
Cancers
Blangero F,Robert M,Andraud T,Dumontet C,Vidal H,Eljaafari A
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Mon May 29 00:00:00 EDT 2023
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity.
Molecular therapy oncolytics
El-Sayes N,Walsh S,Vito A,Reihani A,Ask K,Wan Y,Mossman K
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Immunohistochemistry
Thu Jun 16 00:00:00 EDT 2022
Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer.
Journal for immunotherapy of cancer
Mao M,Chen Y,Yang J,Cheng Y,Xu L,Ji F,Zhou J,Zhang X,Li Z,Chen C,Ju S,Zhang J,Wang L
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Thu Dec 01 00:00:00 EST 2022
Heterogeneity of tyrosine-based melanin anabolism regulates pulmonary and cerebral organotropic colonization microenvironment of melanoma cells.
Theranostics
Wang X,Chen Y,Lan B,Wang Y,Lin W,Jiang X,Ye J,Shang B,Feng C,Liu J,Zhai J,Xu M,Li Q,Lin L,Hu M,Zheng F,Chen L,Shao C,Wang Y,Shi Y
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Thu Apr 21 00:00:00 EDT 2022
CD4+ CTLs Act as a Key Effector Population for Allograft Rejection of MSCs in a Donor MHC-II Dependent Manner in Injured Liver.
Aging and disease
Shen S,Li Y,Jin M,Fan D,Pan R,Lin A,Chen Y,Xiang L,Zhao RC,Shao J
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Thu Dec 01 00:00:00 EST 2022
5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia.
Cancers
Ebelt ND,Manuel ER
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Sun Dec 25 00:00:00 EST 2022
Scoring model based on the signature of non-m6A-related neoantigen-coding lncRNAs assists in immune microenvironment analysis and TCR-neoantigen pair selection in gliomas.
Journal of translational medicine
Zhao W,Wu Y,Zhao F,Xue Z,Liu W,Cao Z,Zhao Z,Huang B,Han M,Li X
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Immunohistochemistry
Sat Oct 29 00:00:00 EDT 2022
Isotope tracing reveals distinct substrate preference in murine melanoma subtypes with differing anti-tumor immunity.
Cancer & metabolism
Zhang X,Halberstam AA,Zhu W,Leitner BP,Thakral D,Bosenberg MW,Perry RJ
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Thu Dec 01 00:00:00 EST 2022
IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis.
Science advances
Garnier L,Pick R,Montorfani J,Sun M,Brighouse D,Liaudet N,Kammertoens T,Blankenstein T,Page N,Bernier-Latamani J,Tran NL,Petrova TV,Merkler D,Scheiermann C,Hugues S
78-5982-82 was used in Flow cytometry/Cell sorting to assess the impact of cytotoxic T cells on the local lymphatic vasculature and concomitant tumor dissemination during an antitumor response.
Fri Jun 10 00:00:00 EDT 2022
Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents.
Journal of nanobiotechnology
Hagemans IM,Wierstra PJ,Steuten K,Molkenboer-Kuenen JDM,van Dalen D,Ter Beest M,van der Schoot JMS,Ilina O,Gotthardt M,Figdor CG,Scheeren FA,Heskamp S,Verdoes M
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Wed Feb 02 00:00:00 EST 2022
Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study.
Clinical and molecular hepatology
Yoo GS,Ahn WG,Kim SY,Kang W,Choi C,Park HC
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Fri Jan 01 00:00:00 EST 2021
Oncolytic herpes simplex virus HF10 (canerpaturev) promotes accumulation of CD8+ PD-1- tumor-infiltrating T cells in PD-L1-enriched tumor microenvironment.
International journal of cancer
Eissa IR,Mukoyama N,Abdelmoneim M,Naoe Y,Matsumura S,Bustos-Villalobos I,Ichinose T,Miyajima N,Morimoto D,Tanaka M,Fujimoto Y,Sone M,Kodera Y,Kasuya H
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Thu Jul 01 00:00:00 EDT 2021
Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer.
mAbs
Xiang H,Chan AG,Ahene A,Bellovin DI,Deng R,Hsu AW,Jeffry U,Palencia S,Powers J,Zanghi J,Collins H
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Immunocytochemistry
Mon Apr 04 00:00:00 EDT 2022
Collagenase-Expressing Salmonella Targets Major Collagens in Pancreatic Cancer Leading to Reductions in Immunosuppressive Subsets and Tumor Growth.
Cancers
Ebelt ND,Zamloot V,Zuniga E,Passi KB,Sobocinski LJ,Young CA,Blazar BR,Manuel ER
78-5982-82 was used in Flow Cytometry to find that ST-SOT treatment significantly modifies the intratumoral immune landscape to generate a microenvironment that may be more conducive to immunotherapy.
Fri Jul 16 00:00:00 EDT 2021
Collagenase-Expressing Salmonella Targets Major Collagens in Pancreatic Cancer Leading to Reductions in Immunosuppressive Subsets and Tumor Growth.
Cancers
Ebelt ND,Zamloot V,Zuniga E,Passi KB,Sobocinski LJ,Young CA,Blazar BR,Manuel ER
78-5982-82 was used in Flow Cytometry to find that ST-SOT treatment significantly modifies the intratumoral immune landscape to generate a microenvironment that may be more conducive to immunotherapy.
Fri Jul 16 00:00:00 EDT 2021
N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells.
Journal for immunotherapy of cancer
Sun Y,Jing J,Xu H,Xu L,Hu H,Tang C,Liu S,Wei Q,Duan R,Guo J,Yang L
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Neutralization
Mon Mar 01 00:00:00 EST 2021
N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells.
Journal for immunotherapy of cancer
Sun Y,Jing J,Xu H,Xu L,Hu H,Tang C,Liu S,Wei Q,Duan R,Guo J,Yang L
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Neutralization
Mon Mar 01 00:00:00 EST 2021
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade.
JCI insight
Ferrere G,Tidjani Alou M,Liu P,Goubet AG,Fidelle M,Kepp O,Durand S,Iebba V,Fluckiger A,Daillère R,Thelemaque C,Grajeda-Iglesias C,Alves Costa Silva C,Aprahamian F,Lefevre D,Zhao L,Ryffel B,Colomba E,Arnedos M,Drubay D,Rauber C,Raoult D,Asnicar F,Spector T,Segata N,Derosa L,Kroemer G,Zitvogel L
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Mon Jan 25 00:00:00 EST 2021
Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion.
Journal of experimental & clinical cancer research : CR
Fang W,Zhou T,Shi H,Yao M,Zhang D,Qian H,Zeng Q,Wang Y,Jin F,Chai C,Chen T
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Neutralization
Mon Jan 04 00:00:00 EST 2021
USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade.
Nature communications
Yang Z,Xu G,Wang B,Liu Y,Zhang L,Jing T,Tang M,Xu X,Jiao K,Xiang L,Fu Y,Tang D,Zhang X,Jin W,Zhuang G,Zhao X,Liu Y
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Wed Aug 11 00:00:00 EDT 2021
Antigen-Capturing Mesoporous Silica Nanoparticles Enhance the Radiation-Induced Abscopal Effect in Murine Hepatocellular Carcinoma Hepa1-6 Models.
Pharmaceutics
Yang K,Choi C,Cho H,Ahn WG,Kim SY,Shin SW,Kim Y,Jang T,Lee N,Park HC
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Fri Oct 29 00:00:00 EDT 2021
Downregulation of PD-L1 via amide analogues of brefelamide: Alternatives to antibody-based cancer immunotherapy.
Experimental and therapeutic medicine
Zhang J,Yamada O,Kida S,Murase S,Hattori T,Oshima Y,Kikuchi H
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Wed Apr 01 00:00:00 EDT 2020
Genetic ablation of adipocyte PD-L1 reduces tumor growth but accentuates obesity-associated inflammation.
Journal for immunotherapy of cancer
Wu B,Chiang HC,Sun X,Yuan B,Mitra P,Hu Y,Curiel TJ,Li R
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Sat Aug 01 00:00:00 EDT 2020
Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms.
Journal for immunotherapy of cancer
Neuwelt AJ,Kimball AK,Johnson AM,Arnold BW,Bullock BL,Kaspar RE,Kleczko EK,Kwak JW,Wu MH,Heasley LE,Doebele RC,Li HY,Nemenoff RA,Clambey ET
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Wed Apr 01 00:00:00 EDT 2020
CD279 mediates the homeostasis and survival of regulatory T cells by enhancing T cell and macrophage interactions.
FEBS open bio
Liu Y,Gao Y,Hao H,Hou T
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Functional assay
Mon Jun 01 00:00:00 EDT 2020
CD279 mediates the homeostasis and survival of regulatory T cells by enhancing T cell and macrophage interactions.
FEBS open bio
Liu Y,Gao Y,Hao H,Hou T
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Functional assay
Mon Jun 01 00:00:00 EDT 2020
Nuclear imaging-guided PD-L1 blockade therapy increases effectiveness of cancer immunotherapy.
Journal for immunotherapy of cancer
Gao H,Wu Y,Shi J,Zhang X,Liu T,Hu B,Jia B,Wan Y,Liu Z,Wang F
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Sun Nov 01 00:00:00 EDT 2020
Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Restructures the Immune Contexture to Improve Checkpoint Blockade Efficacy.
Biomedicines
Ebelt ND,Zuniga E,Marzagalli M,Zamloot V,Blazar BR,Salgia R,Manuel ER
78-5982 was used in Flow cytometry/Cell sorting to suggest that the success of ICB therapy may be more accurately predicted by taking into account multiple factors such as potential for antigen presentation and immune subset repertoire in addition to markers already being considered.
Wed Dec 16 00:00:00 EST 2020
Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
Molecular oncology
Zhou Z,Chen H,Xie R,Wang H,Li S,Xu Q,Xu N,Cheng Q,Qian Y,Huang R,Shao Z,Xiang M
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Mon Apr 01 00:00:00 EDT 2019
Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway.
Journal of experimental & clinical cancer research : CR
Shen M,Xu Z,Xu W,Jiang K,Zhang F,Ding Q,Xu Z,Chen Y
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Neutralization
Mon Apr 08 00:00:00 EDT 2019
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.
The Journal of clinical investigation
Zamarin D,Ricca JM,Sadekova S,Oseledchyk A,Yu Y,Blumenschein WM,Wong J,Gigoux M,Merghoub T,Wolchok JD
Published figure using CD274 (PD-L1, B7-H1) monoclonal antibody (Product # 78-5982-82) in Flow Cytometry
Mon Apr 02 00:00:00 EDT 2018